policy

Transparency

The Business Group strongly supports efforts to promote healthcare price and quality transparency. In particular, we believe that all relevant information needed to select from among physicians, hospitals, and other health care providers, should be made available to patients in a meaningful, user-friendly way prior to their need to choose where to seek treatment. We believe that transparency is foundational to consumerism, fosters competition among providers and hospitals, and promises to increase efficiency and reduced costs. Finally, the structure of consumer directed health plans creates a demand for more healthcare transparency, especially as it pertains to costs of services and out-of-pocket expenses.

However, the healthcare market is uniquely difficult to navigate and often people don’t know the true costs of services until after they have received them. Complicating the lack of transparency is the wide variety in pricing by site of care. Greater transparency around prices of healthcare services will enable employees and their families to choose lower-cost, high-value and high-quality care and promote competition in the market.

Top RightThis Numbers You Need chart contains data on the types of value-based benefits designs employers have integrated into their plans.

 

 

Featured Resources

Transparency Tools: Side-By-Side Comparisons Transparency Tools: Side-By-Side Comparisons
This document provides large employers with a landscape analysis of the companies that provide transparency tools to employees and their dependents. The table below provides an overview of companies offering these types of services, including information on: the services they offer, distinguishing characteristics and reported outcomes.

National Business Group on Health's Position Statement on Transparency National Business Group on Health's Position Statement on Transparency
Transparency is essential to high quality and affordable health care.

Comments to the National Institutes of Health (NIH) on Their Proposal to Clarify and Expand Clinical Trial Data Reporting Comments to the National Institutes of Health (NIH) on Their Proposal to Clarify and Expand Clinical Trial Data Reporting
The National Business Group on Health's comment letter to the National Institutes of Health (NIH) on its proposal to clarify and expand the requirements for reporting clinical trial data to the public.

 

 

LinkedIn Twitter